NCT04114669Completed
Behavioral Economics Trial To Enhance Regulation of Blood Pressure (BETTER-BP)
Behavioral Economics Trial To Enhance Regulation of Blood Pressure
Source: ClinicalTrials.gov · Last updated 27 May 2026
Brief summary (registry, in English)
BETTER-BP (Behavioral Economics Trial To Enhance Regulation of Blood Pressure) is a phase II, single-center, prospective, pragmatic randomized clinical trial within the New York City Health and Hospitals (NYC-H+H) system and NYU Langone Family Health Centers. The trial will recruit from 3 NYC-H+H ambulatory clinics as well as NYU Langone Family Health Centers, and will use a lottery incentive program to promote adherence to antihypertensive medication that will be delivered via smartphone for 6 months. The trial will randomize 435 patients with hypertension determined to have poor adherence (\<80% adherence with antihypertensive medication), in a 2:1 (intervention:control) ratio. Baseline enrollment will occur over 36 months with an expected 12 months follow-up per participant.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 401 (actual)
- First submitted
- 20 Sept 2019
- Start date
- 14 Jul 2020
- Primary completion date
- 12 May 2025
- Lead sponsor
- NYU Langone Health
- Diseases
- High blood pressure
- NCT number
- NCT04114669
What you commit to
- Study type: Interventional
- Participants enrolled: 401
- From 14 Jul 2020 to the primary completion date, 12 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Clear barrier to technology use (e.g. visual or hearing impairment)
Other
- Incarcerated
- Pregnant
- Unable to use study software (Way To Health) in English or Spanish
- Unable/unwilling to consent
- Projected life expectancy \<12 months
Who the study is looking for
- A diagnosis of hypertension.
- An active prescription for ≥1 antihypertensive medication (any of the following classes: thiazide diuretic, ACE inhibitor, angiotensin receptor blocker, beta blocker, calcium channel blocker, centrally acting alpha agonist, direct vasodilator).
- 1 ambulatory systolic blood pressure ≥140 mmHg (on therapy).
- Suboptimal adherence (self-report).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NYU Langone Health Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.